Investigation of novel chemical scaffolds targeting prolyl oligopeptidase for neurological therapeutics-Reference-Cited by-同舟云学术

Investigation of novel chemical scaffolds targeting prolyl oligopeptidase for neurological therapeutics

Published:2019-05 Issue: Volume:88 Page:92-103
ISSN:1093-3263
Container-title:Journal of Molecular Graphics and Modelling
language:en
Short-container-title:Journal of Molecular Graphics and Modelling

Author:

Kumar Raj,Parameswaran Saravanan,Bavi Rohit,Baek Ayoung,Son Minky,Rampogu Shailima,Park Chanin,Lee Gihwan,Zeb Amir,Parate Shraddha,Rana Rabia Mukhtar,Lee Keun Woo

Funder

Bio & Medical Technology Development Program of the National Research Foundation of KoreaBio & Medical Technology Development Program of the National Research Foundation of Korea (NRF)

Korean government

Publisher

Elsevier BV

Subject

Materials Chemistry,Computer Graphics and Computer-Aided Design,Physical and Theoretical Chemistry,Spectroscopy

Reference47 articles.

1. The prolyl oligopeptidase family;Polgar;Cell. Mol. Life Sci.: CMLS,2002

2. Leucylglycinamide released from oxytocin by human uterine enzyme;Walter;Science,1971

3. Structure, function and biological relevance of prolyl oligopeptidase;Szeltner;Curr. Protein Pept. Sci.,2008

4. Subcellular localization suggests novel functions for prolyl endopeptidase in protein secretion;Schulz;J. Neurochem.,2005

5. Prolyl oligopeptidase binds to GAP-43 and functions without its peptidase activity;Di Daniel;Mol. Cell. Neurosci.,2009

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, Molecular Docking Studies and Biological Evaluation of Thiazolyl Hydrazone Derivatives of Chromone-3-carbaldehyde as Potent Anti-Oxidant and Anti-Inflammatory Agents;Medicinal Chemistry;2024-10

2. Identification of ACK1 inhibitors as anticancer agents by using computer-aided drug designing;Journal of Molecular Structure;2021-07

3. Computational Simulations Identified Marine-Derived Natural Bioactive Compounds as Replication Inhibitors of SARS-CoV-2;Frontiers in Microbiology;2021-04-21

4. Identification of Flavonoids as Putative ROS-1 Kinase Inhibitors Using Pharmacophore Modeling for NSCLC Therapeutics;Molecules;2021-04-07

5. Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2;Journal of Pharmaceutical Sciences;2021-03